Candel Therapeutics (CADL) Non-cash Items (2020 - 2025)

Candel Therapeutics' Non-cash Items history spans 4 years, with the latest figure at $199000.0 for Q4 2023.

  • On a quarterly basis, Non-cash Items fell 93.08% to $199000.0 in Q4 2023 year-over-year; TTM through Dec 2023 was $199000.0, a 93.08% decrease, with the full-year FY2023 number at $3.7 million, up 27.13% from a year prior.
  • Non-cash Items hit $199000.0 in Q4 2023 for Candel Therapeutics, down from $3.5 million in the prior quarter.
  • Over the last five years, Non-cash Items for CADL hit a ceiling of $13.8 million in Q4 2020 and a floor of $199000.0 in Q4 2023.
  • Historically, Non-cash Items has averaged $4.1 million across 4 years, with a median of $2.6 million in 2022.
  • The widest YoY moves for Non-cash Items: up 314.85% in 2023, down 93.08% in 2023.
  • Tracing CADL's Non-cash Items over 4 years: stood at $13.8 million in 2020, then crashed by 85.15% to $2.1 million in 2021, then soared by 40.16% to $2.9 million in 2022, then crashed by 93.08% to $199000.0 in 2023.
  • Business Quant data shows Non-cash Items for CADL at $199000.0 in Q4 2023, $3.5 million in Q3 2023, and $10.0 million in Q2 2023.